In general, previous studies in mouse models indicate that in response to a metabolic challenge with high-fat diet (HFD), loss of Ffar4 worsens metabolic disease, with evidence of insulin resistance, glucose intolerance, adipose dysfunction, and fatty liver but with little or no effect on weight gain (20, 21, 22, 23). This evidence concerns the gene FFAR4 and metabolic disease.